Topic
IPO Research
The current environment for IPOs is shaped by a resilient but narrow market rally, primarily driven by technology and software sector gains that set a high performance bar for new entrants. Research indicates a significant pipeline of potential candidates emerging from the massive AI buildout, where hyperscaler capital expenditure is projected to hit $1 trillion annually by 2028. While private equity and venture capital continue to attract interest due to historical outperformance, the rise of liquid vehicles tracking these segments has increased their correlation with public large-cap benchmarks. Institutional sentiment remains focused on quality fundamentals and U.S. large-cap core exposure, suggesting that upcoming offerings will face rigorous scrutiny regarding leverage and valuation metrics. Furthermore, expectations of stable Federal Reserve policy in the near term, followed by potential rate cuts as growth slows, may provide a stabilizing macro backdrop for valuation discovery. Ultimately, the research suggests that while market volatility remains a concern, the strategic shift toward active management and private market diversification is redefining the bridge between private funding and public equity listings.
4275 reports available
All reports
Page 66 of 127
Nvidia Vera Rubin Rack Cost Analysis
Morgan Stanley · May 24, 2026
Weekly Fund Flows: Europe Buys US Again
Goldman Sachs · May 24, 2026
UK Weekly Kickstart: When Weak Growth Meets Fiscal Limits
Goldman Sachs · May 24, 2026
Food for Thought: Global Data Points and End-Market Commentary
Goldman Sachs · May 24, 2026
China Beverages: Cost Inflation and Competitive Positioning
Goldman Sachs · May 24, 2026
Higher Likelihood of an Early Election Implies Higher Rates for Longer
Goldman Sachs · May 24, 2026
Reestablishing Momentum
Goldman Sachs · May 24, 2026
Hedge Funds Have Made Back Their War Losses
Bloomberg · May 24, 2026
Memorial Day Melt-Up
Goldman Sachs · May 24, 2026
Stocks and Bonds are on a Collision Course
BCA Research · May 24, 2026
Japan Pharmaceuticals ASCO Trial Updates
Goldman Sachs · May 24, 2026
European Express
Goldman Sachs · May 24, 2026
Dutch Life Insurance Market and Ageas Reinstatement
Goldman Sachs · May 24, 2026
Americas Energy: Oil - Refining - Lower Mid-Con Inventory Levels and Feedstock Advantage Support Positive 2Q Revisions
Goldman Sachs · May 24, 2026
China Cosmetics 618 Pulse Check
Goldman Sachs · May 24, 2026
Wus Management Visit Positive on Ai Pcb Demand and Capacity Expansion
Goldman Sachs · May 24, 2026
Europe Weekly Kickstart
Goldman Sachs · May 24, 2026
Early Morning Research Recap: Ratings and Target Price Changes
Goldman Sachs · May 24, 2026
Pasquariello Answers Money Managers Top 5 Questions
Goldman Sachs · May 24, 2026
Asia Pacific Weekly Kickstart
Goldman Sachs · May 24, 2026
Korea Weekly Kickstart
Goldman Sachs · May 24, 2026
VF Corp F4Q26 Earnings Review
Goldman Sachs · May 24, 2026
Connecting the Dots: Rates Volatility, AI Investment and Oil Capex
Goldman Sachs · May 24, 2026
Japan Weekly Kickstart
Goldman Sachs · May 24, 2026